Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 50,000 FDMT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 50,000 | n/a |
| Dec 16, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 9,333 | $10.6K |
| Jun 20, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 22,500 | n/a |
| Jun 24, 2024 | Oncternal Therapeutics, Inc. (ONCT) | Grant/Award | 2,200 | n/a |
| May 23, 2024 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 22,500 | n/a |
| Mar 13, 2024 | Tracon Pharmaceuticals, Inc. (TCON) | Grant/Award | 3,500 | $481.95 |
| May 25, 2023 | 4D Molecular Therapeutics, Inc. (FMDT) | Grant/Award | 22,500 | n/a |
| May 25, 2022 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 22,500 | n/a |
| May 20, 2021 | 4D Molecular Therapeutics Inc. (FDMT) | Grant/Award | 22,500 | n/a |